EUROLyser Revenue and Competitors
Estimated Revenue & Valuation
- EUROLyser's estimated annual revenue is currently $840k per year.
- EUROLyser's estimated revenue per employee is $84,000
Employee Data
- EUROLyser has 10 Employees.
- EUROLyser grew their employee count by 0% last year.
EUROLyser's People
Name | Title | Email/Phone |
---|
EUROLyser Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $12.6M | 90 | -36% | $14.1M | N/A |
#2 | $83.2M | 468 | -3% | $251M | N/A |
#3 | $14M | 100 | 1% | N/A | N/A |
#4 | $14.6M | 0 | N/A | $12.5M | N/A |
#5 | $30.3M | 197 | -6% | N/A | N/A |
#6 | $0.1M | 6 | -25% | $2.6M | N/A |
#7 | $45.1M | 293 | 2% | N/A | N/A |
#8 | $4.8M | 43 | -7% | N/A | N/A |
#9 | $399.3M | 2037 | 40% | N/A | N/A |
#10 | $44M | 286 | 4% | N/A | N/A |
What Is EUROLyser?
Who are we? Eurolyser Diagnostica has been a global player in the point-of-care testing business for more than 15 years. We are a heavily research driven company and as such have accumulated very specific expertise that allows us to design and manufacture cutting edge technology instruments and test kits. Our products are durable, versatile, maintenance free and – most importantly – every bit as precise as large-scale laboratory devices. We are committed to significantly improve healthcare. Specifically one of its most important aspects: Point-of-care diagnostics. For the benefit of both doctors and patients! What drives us? At Eurolyser, health management and healthcare are our primary concern. We are convinced that medical diagnostics are a key element of modern day healthcare. The faster and more precise a doctor can determine what the patient needs, the faster they can commence treatment. How do we achieve that? We develop and distribute point-of-care instruments and test kits for doctor's practises or hospital's ERs. We consider this the next logical step in high-quality healthcare. Our products and services are designed to be beneficial for all relevant parties involved: - It allows physicians to become more independent from laboratories (think waiting periods and paperwork) - Hospitals also strongly benefit from the sped up process - specifically in ERs, where every minute counts - Patients enjoy a significant reduction of necessary visits to hospitals or practices since test results are available within minutes rather than days. - Due to the reductions in redundancies and idle times the healthcare system as a whole will become more efficient and less expensive. For governments and, last but not least, taxpayers. In other words: for every one!
keywords:N/AN/A
Total Funding
10
Number of Employees
$840k
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
EUROLyser News
Ltd., DiaSys Diagnostic Systems GmbH, Diconex SA, ELITech Group, Eurolyser Diagnostics GMBH, Heska Corp., HORIBA Ltd., IDEXX Laboratories...
Eurolyser Diagnostica GmbH, Cortez Diagnostics Inc., bioMérieux SA, Doctorcall, Aviva Systems Biology Corporation, Biopanda Reagents Ltd,...
... Quidel Corporation, Osang Healthcare, Gencurix, Eurolyser Diagnostica, iDNA, GRAIL, imaware, Check4Cancer, Labcorp, and Cologuard.
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $2.1M | 13 | -13% | N/A |
#2 | $1.3M | 15 | N/A | N/A |
#3 | $3.2M | 21 | N/A | N/A |
#4 | $2.9M | 25 | 9% | N/A |
#5 | N/A | 25 | 39% | N/A |